Education

Ph.D., Tianjin Medical University (2017)

Professional Membership

Tianjin Anti-Cancer Association Translational Medicine Group, Vice director member ;

Expertise: Medical Oncology

Dr. Zhang has been engaged in medical oncology for a long time. She is rich in clinical experience of hepatobiliary malignant diseases treatment, and has been responsible for several clinical trials. Moreover, she is also an active scientific researcher and has made a lot of important findings published in various SCI journals.

Typical Papers

1. Zhang NN, Jiang W, Zhang Y, et al. Individualized tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria[J]. Gut, 2019:gutjnl-2019-320073.

2. Zhang NN, Jiang W, Zhang Y, et al. A novel tailored prognosis calculator for the individualized curative treatments allocation of HCC patients within the Milan criteria[J]. Journal of Hepatology, 2020, 73:S100-S101.

3. Zhang NN, Xie H, Li JF, et al. Chloroquine sensitizes hepatocellular carcinoma cells to chemotherapy via blocking autophagy and promoting mitochondrial dysfunction. Int J Clin Exp Pathol.2017,10(9):10056-10065.

4. Li JF, Wang PM, Zhang NN, et al. Hypoxia-induced miR-17-5p ameliorates the viability reduction of astrocytes via targeting p21[J]. Eur Rev Med Pharmacol, 2016, 20(14):3051-3059.

5. Zhang NN, Lu W, Cheng XJ, et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Clinical Radiology. 2015,vol.70:1237-1243.

Visiting time

Monday afternoons, Wednesday mornings, Friday mornings